The prevalence of food hypersensitivity in the UK is still largely open to debate. Additionally its pathogenesis is also unclear although it is known that there are differing phenotypes.
Follow, research and publish the best content
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
Allergy (and clinical immunology)
16.2K views |
+1 today
Ressources et Actualités pour la spécialité Allergie
Curated by
Gilbert C FAURE
 Your new post is loading...
Your new post is loading...
Scoop.it!
Transfusion. 2016 Jan 18. doi: 10.1111/trf.13451. [Epub ahead of print] 
Scoop.it!
Avoid #peanut_allergy by introducing #peanuts into an infants diet early, rather than later.. http://t.co/CUh84IMZN8
Scoop.it!
A small French biopharmaceutical company has developed a new patch to help allergy sufferers increase their peanut tolerance.
Scoop.it!
Giving mice common intestinal bacteria eliminated peanut allergies
Scoop.it!
by Christian Schwager, Skadi Kull, Susanne Krause, Frauke Schocker, Arnd Petersen, Wolf-Meinhard Becker, Uta Jappe
Scoop.it!
Original Article from The New England Journal of Medicine — Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
Scoop.it!
Original Article from The New England Journal of Medicine — Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
Scoop.it!
2015 review of recent research and relevant data that can help put peanut and food allergies in context, with a look at medical facts and trends relating to regulation.
Scoop.it!
Melbourne-based study of children given nut protein with probiotic has transformed the lives of 80% of those who took part in clinical trial Via ReactNow
Scoop.it!
RT @GoAllergy: Editors choice! Well done @alex_fsantos Use of BAT in predicting dose & severity of peanut reactions. http://t.co/AR3JvwhE70
Scoop.it!
DBV Technologies SA has drawn suitors after its peanut allergy patch showed positive results in early tests. The company is spurning advances because it wants to go it alone.
Scoop.it!
Immunoassay recognises immunoglobulins for both peptide and carbohydrate epitopes
|
Scoop.it!
Peanut allergy is an IgE-mediated adverse reaction to a subset of proteins found in peanuts. Immunotherapy aims to desensitize allergic patients through repeated and escalating exposures for several months to years using extracts or flours.
Scoop.it!
This consensus communication focuses on new data that support introducing peanuts early in infants, and it aims to assist with decisions about introduction; it can be used for guidance while formal guidelines are being developed.
Scoop.it!
US money keeps flowing into Europe's biotechs. As the race for the peanut allergy market heats up, NASDAQ listed French biotech DBV has announced the successful closing of US$281m (€256m) share offering for its allergy products.
Scoop.it!
The European Academy of Allergy and Clinical Immunology (EAACI) recently held its 2015 Annual Congress in Barcelona, Spain. FARE CEO Dr. James R. Baker, Jr. and FARE SVP of Research and Operations ...
Scoop.it!
The FDA granted breakthrough therapy designation to Viaskin Peanut, an epicutaneous delivery system, for the treatment of children aged 6 to 11 years with peanut allergy, according to a manufacturer’s press release.The Viaskin Peanut (DBV Technologies)...
Scoop.it!
French biopharmaceutical company DBV Technologies moves closer to bringing its peanut allergy patch to market, receiving Breakthrough Therapy Designation from the U.S. Food and Drug Administration as it prepares to launch its Phase 3 trial.
Scoop.it!
From BioPortfolio: Epicutaneous Immunotherapy (EPIT) introduces new way to treat peanut allergies Houston, TX (PRWEB) February 22, 2015 A team of researchers unveiled the results ...
Scoop.it!
Eating peanut products as a baby dramatically cuts the risk of allergy, a study suggests.
Scoop.it!
Clinical trial transforms the lives of 80 per cent of young participants with potentially fatal allergies. Via Peter Mellow
Scoop.it!
Allergy Immunology | The administration of a probiotic with peanut oral immunotherapy increased sustained unresponsiveness in children with peanut allergy, according to recent study results.The researchers conducted a double blind,...
Scoop.it!
French biotech firm DBV Technologies has created a patch which administers small amounts of the peanut allergen to the skin, so over time the immune system becomes used to it.
Scoop.it!
A new study led by researchers at King's College London in collaboration with the US Consortium of Food Allergy Research and the University of Dundee has found a strong link between environmental exposure to peanut protein during infancy (measured...
|
Cumulative incidence of food hypersensitivity by 2 years of age was 5.0 %. The cumulative incidence for individual food allergens were hens’ egg 2.7 % (1.6–3.8); cows’ milk 2.4 % (1.4–3.5); peanut 0.7 % (0.1–1.3); soy 0.4 % (0.0–0.8); wheat 0.2 % (0.0–0.5) and 0.1 % (0.0–0.32) for fish. The cumulative incidence of IgE-mediated food allergy was 2.6 % with 2.1 % reacting to hens’ egg. For non-IgE-mediated food allergy the cumulative incidence was 2.4 % (cows’ milk 1.7 %). Predictors for any food hypersensitivity were wheeze, maternal atopy, increasing gestational age, age at first solid food introduction and mean healthy dietary pattern score. Predictors for IgE mediated allergy were eczema, rhinitis and healthy dietary pattern score whereas for non-IgE-mediated food allergy the predictors were dog in the home, healthy dietary pattern score, maternal consumption of probiotics during breastfeeding and age at first solid food introduction.
ConclusionsJust under half the infants with confirmed food hypersensitivity had no demonstrable IgE. In an exploratory analysis, risk factors for this phenotype of food hypersensitivity differed from those for IgE-mediated food allergy except for a healthy infant diet which was associated with less risk for both phenotypes.
OPEN